Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: Analysis of data from the National Ambulatory Medical Care Survey

Journal of Dermatological Treatment

Volumn 23, Issue 4, 2012, Pages 272-277

  Landis, Erin T ^a   Levender, Michelle M ^a   Davis, Scott A ^a   Feneran, Ashley N ^a   Gerancher, Karen R ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Accutane; Medical specialties; OCPs; Population surveillance

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETYNODIOL DIACETATE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; ETHINYLESTRADIOL PLUS NORGESTREL; ISOTRETINOIN; MESTRANOL PLUS NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

ACNE; ADOLESCENT; ADULT; CHILD; DERMATOLOGIST; DRUG SAFETY; DRUG UTILIZATION; FAMILY MEDICINE; FEMALE; GYNECOLOGIST; HUMAN; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; ORAL CONTRACEPTION; OTORHINOLARYNGOLOGY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; TERATOGENICITY;

ACNE VULGARIS; ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL; DERMATOLOGIC AGENTS; DRUG PRESCRIPTIONS; FEMALE; HEALTH CARE SURVEYS; HUMANS; ISOTRETINOIN; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; YOUNG ADULT;

EID: 84863942662     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2012.671908     Document Type: Review

References (14)

1. Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E, et al. The burden of skin diseases: 2004. A joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006;55:490-500.
2. Fried RG, Webster GF, Eichenfield LF, Friedlander SF, Fowler JF Jr, Levy ML. Medical and psychosocial impact of acne. Semin Cutan Med Surg. 2010;29(2 Suppl 1):9-12.
3. Fried RG, Wechseler A. Psychological problems in the acne patient. Dermatol Ther. 2006;19:237-240.
4. Dunn LK, O'Neill JL, Feldman SR. Acne in adolescents: Quality of life, self-esteem, mood, and psychological disorders. Dermatol Online J. 2011;17:1.
5. Krakowski AC, Stendardo S, Eichenfield LF. Practical considerations in acne treatment and the clinical impact of topical combination therapy. Pediatr Dermatol. 2008;25(Suppl 1): 1-14.
6. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA. 2004; 292:726-735.
7. Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56: 651-663.
8. Honein MA, Paulozzi LJ, Erickson JD. Continued occurrence of accutane-exposed pregnancies. Teratology. 2001;64: 142-147.
9. Schonfeld TL, Amoura NJ, Kratochvil CJ. iPLEDGE allegiance to the pill: Evaluation of year 1 of a birth defect prevention and monitoring system. J Law Med Ethics. 2009;37:104-117. 16 14 12 10 8 6 4 2 0 -2 -4 1996 1998 2000 2002 2004 2006 2008 Total OCP use by dermatologists for acne, 1997-2008 Linear (Total OCP use by dermatologists for acne, 1997-2008 Figure 1. Percent oral contraceptive use by dermatologists for acne from 1997 to 2008 with linear regression
10. Tan J. Hormonal treatment of acne: Review of current best evidence. J Cutan Med Surg. 2004;8(Suppl 4):11-15.
11. Katsambas AD, Dessinioti C. Hormonal therapy for acne: Why not as first line therapy? Facts and controversies. Clin Dermatol. 2010;28:17-23.
12. Spencer AL, Bonnema R, McNamara MC. Helping women choose appropriate hormonal contraception: Update on risks, benefits, and indications. Am J Med. 2009;122:497-506.
13. Fleischer AB Jr, Feldman SR, Bradham DD. Office based physician services provided by dermatologists in the US in 1990. J Invest Dermatol. 1994;102:93-97.
14. Fleischer AB Jr, Feldman SR, White RE, Leshin B, Byington R. Procedures for skin diseases performed by physicians in 1993 and 1994: Analysis of data from the National Ambulatory Medical Care Survey. J Am Acad Dermatol. 1997;37(5 Pt 1):719-724.